Discovery provides therapeutic target for amyotrophic lateral sclerosis
Researchers have found that the ability of a protein made by a gene called FUS to bind to RNA is essential to the development of amyotrophic lateral sclerosis (ALS). This discovery identifies a possible therapeutic target for the fatal neurological disease. View full story